Clinical experience in india with a once-a-month oral contraceptive pill: qingestanol and quinestrol.
D000293:Adolescent; D000328:Adult; D004341:Drug Evaluation; D005260:Female; D005298:Fertility / Q000187:drug effects*; D006801:Humans; D008599:Menstruation Disturbances / Q000139:chemically induced; D008875:Middle Aged; D009325:Nausea / Q000139:chemically induced; D009649:Norpregnadienes / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D009651:Norpregnatrienes / Q000494:pharmacology*; D010298:Parity; D011247:Pregnancy; D011800:Quinestrol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*
D009649:Norpregnadienes; D009651:Norpregnatrienes; D011800:Quinestrol